急性呼吸窘迫综合征(ARDS)作为重症监护室(ICU)内高死亡率的危重症,至今仍未找到确切的早期生物学标志物与治疗靶点。目前,由于代谢组学研究的快速发展,尤其以脂质代谢组学的快速发展,为我们解决这一难题提供了可能。本文就脂质代谢组学在ARDS中的研究进展做一综述。
Acute respiratory distress syndrome (ARDS) is a common critical condition with high mortality in the intensive care unit. However, exact early biomarkers and therapeutic targets have not been found so far. At present, the rapid development of metabolomics research, especially the rapid development of lipidomics, provides the possibility to solve this problem for us. Therefore, this article reviews the development of lipidomics in ARDS.